|
Characteristic
|
N
|
CLDN6 Expression
|
P value
|
|---|
|
High
|
Low
|
|---|
|
Breast cancer tissues
|
30
|
7 (23.33 %)
|
23 (76.67 %)
| |
|
Pericarcinomatous tissues
|
10
|
10 (100 %)
|
0 (0 %)
|
P < 0.05
|
|
Age (years)
| | | | |
|
20–40
|
9
|
2 (22.22 %)
|
7 (77.78 %)
| |
|
40–60
|
14
|
3 (21.43 %)
|
11 (78.57 %)
| |
|
60–80
|
7
|
2 (28.57 %)
|
5 (71.43 %)
|
P > 0.05
|
|
Tumor status
| | | | |
|
T1
|
13
|
2 (15.38 %)
|
11 (84.62 %)
| |
|
T2
|
12
|
4 (33.33 %)
|
8 (66.67 %)
| |
|
T3
|
5
|
1 (20 %)
|
4 (80 %)
|
P > 0.05
|
|
Clinical stage
| | | | |
|
Is-I
|
14
|
4 (28.57 %)
|
10 (71.43 %)
| |
|
II-IV
|
16
|
3 (18.75 %)
|
13 (81.25 %)
|
P > 0.05
|
|
Node status
| | | | |
|
+
|
19
|
2 (10.53 %)
|
17 (89.47 %)
| |
|
–
|
11
|
5 (45.45 %)
|
6 (54.55 %)
|
P < 0.05
|
-
P value was measured with student’s t test. Significance of association was determined using a χ2 test
